Collegium Pharma (COLL) Misses Q1 EPS by $1.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Collegium Reports First Quarter 2022 Financial Results
May 10, 2022 4:01 PM EDT- Generated Net Revenue of $83.8 Million -
- Completed BDSI Acquisition; On Track to Exceed Targeted Run Rate Synergies of at Least $75 Million -
- Resolved All Opioid-Industry Litigation -
- Reaffirms 2022 Financial Guidance -
- Conference Call Scheduled for Today at 4:30 p.m. ET -
STOUGHTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) --... More
